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The results reported in the preceding communication (1)  disclose 
the fact that the antibody responses to the injection of heat-killed 
pneumococci differ qualitatively, and that the nature of the response 
is related to the route of administration of the organisms.  Pneumo- 
cocci of Type I, which are invariably effective in stimulating the for- 
mation of type-specific antibodies when they are introduced intra- 
venously, were ineffective in producing this type of antibody response 
in 88 per cent of the rabbits when the injections were made intra- 
cutaneously.  Under  the  latter  conditions,  the  antibody  response 
was solely or predominantly species-specific  and was no different from 
the response of rabbits to the intracutaneous injection of S cells of 
different types, or, indeed, of degraded, non-type-specific R organisms. 
The question naturally suggests itself whether rabbits which have 
received repeated  intracutaneous injections of heat-killed pneumo- 
cocci, and therefore have in their sera no type-specific antibodies, are, 
nevertheless, actively resistant to infection, and if so, whether  this form 
of acquired resistance is likewise effective against infection by heterol- 
ogous types of Pneumococcus.  The question also arises whether the 
sera of animals immunized by intracutaneous injections will confer 
passive protection upon white mice against infection by homologous 
types of Pneumococcus.  A preliminary report (2) has already been 
made of the experiments here presented  which were undertaken  to 
solve these problems. 
EXPEI~IMENTAL 
Rabbits were immunized  by repeated intracutaneous  injections.  The inocula- 
tions were made once a week and consisted of 0.2 cc. of a suspension of heat-killed 
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bacteria, or the equivalent of 2.0 cc. of broth culture.  The degree of resistance 
to infection was determined 10 to 21 days after the last intracutaneous inocula- 
tion by injecting intravenously varying quantities  of live virulent cultures of 
Type I  or Type III pneumococci.  The Type I  strain -killed normal rabbits in 
amounts of 10 -7 cc. of broth culture, while the Type III strain was fatal  in an 
amount of 10 -3 cc. to 10 -4 cc.  Samples of blood were obtained from the rabbits 
immediately preceding infection and the sera were used to determine the titre of 
type-specific agglutinins and also the power to protect white mice against infec- 
tion by pneumococci of homologous types. 
Resistance  to  Infection  Following  [ntracutaneous  Immunization  with 
Heat-Killed "S" Cells of Pneumococcus 
I.  Immunization with Type I  (S) Pneumococcus 
Forty rabbits were immunized intracutaneously  to  Type I  Pneu- 
mococcus and  tested  later  for their  resistance  to  infection.  In  the 
earlier experiments the resistance to infection by the homologous type 
of Pneumococcus was determined, while in the later experiments the 
degree of active immunity to infection by some type of Pneumococcus 
other than that used for immunization was tested. 
(a) Active Resistance to Infection by Pneumococcus  Type I  (Homolo- 
gous).  Resistance to infection by the homologous type of Pneumo- 
coccus was first determined in a  group of three  rabbits (Table I). 
Each had received into the skin 12 injections of suspensions of heat-killed pneu- 
mococci, the total number of bacteria injected being equivalent to those contained 
in 27 cc. of broth culture.  Twelve days after the last inoculation all the animals 
were given intravenously 0.1  cc.  of living virulent Type I  culture, and all sur- 
vived.  Control, normal rabbits died within 48 hours after receiving 0.0,000,001 
cc. of the same culture.  The serum of one of the 3 immunized rabbits possessed 
an agglutinin titre for the type-specific organism of 1:1; sera from the other two 
rabbits had no agglutinating power.  A second group of 9 rabbits received 8 in- 
jections of heat-killed pneumococci equivalent to those contained in  16 cc. of 
broth  culture.  Subsequently  they  survived the  intravenous  injection  of  live 
cultures in quantities as large as 0.2 co., whereas normal rabbits succumbed follow- 
ing injections of 0,0,000,001 cc.  In only 3 of the rabbits were type-specific agglu- 
tinins demonstrable. 
These observations demonstrate that intracutaneous immunization 
with heat-killed Type I  pneumococci is followed by resistance to the 
intravenous injection of virulent cultures of the same type. 
(b) A ctive Resistance to Infection by Type III Pneumococci  (Heterol- LOUIS  A.  JULIANELLE  451 
ogous).  The foregoing experiment shows that rabbits may acquire 
an effective resistance to infection by the same organism used in im- 
munization, even when demonstrable circulating type-speclfic anti- 
bodies  are  absent.  Consequently it  was  interesting to  determine 
whether.this form of resistance is also effective against infection with 
pneumococci of heterologous types.  Accordingly, in all the following 
experiments resistance was determined to infection by Pneumococcus 
Type III.  In Table I  are given results  of these experiments in 31 
rabbits.  It is evident that following intracutaneous administration 
of suspensions of heat-killed Type I  pneumococci, rabbits acquire a 
marked degree of resistance to infectionby  virulent Type III organisms. 
In a general way, the resistance increases with the number of injec- 
tions.  However, in the last experiment given in Table I  the rabbits 
received only one injection and yet they were resistant to 100 lethal 
doses of Pneumococcus Type III. 
(c)  Passive Immunity.  It is seen, then, that rabbits may be actively 
immunized  byintracutaneous injections, not only against pneumococci 
of the type used in immunization but also against pneumcococci of 
other types, and this in the absence of circulating type-specific anti- 
bodies.  It was interesting to determine whether the sera of these 
rabbits protected white mice against infection.  Protection tests were 
conducted in the usual manner by the simultaneous intraperitoneal 
injection  of  0.2 cc. of serum and varying dilutions of Type I Pneumococ- 
cus culture.  The sera of 53 animals were tested (Tables I and III); the 
sera of 42 of them showed no measurable protective properties for mice, 
while the sera of the remaining 11 exhibited protective power against 
only very  small infecting doses of Pneumococcus Type  I  culture. 
Of the  11  sera which were protective, 6  contained no type-specific 
agglutinins while  5  showed type-specific agglutiuin titres  of  1:1- 
1 : 20.  On the other hand, of the 42 sera with no protective capacity 
only one showed type-specific agglutinins, and in this case the agglu- 
tination titre was 1 : 3.  It is evident, therefore, that in most instances 
in which the sera possessed protective power this was associated with 
the presence of type-specific agglutinins.  On the other hand, in most 
of the animals the sera possessed no protective power for mice and no 
type-specific agglutinins.  It is possible, however, as the work of Til- 
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TABLE  I 
Resistance o/Rabbits to Infection Following Intracutaneous Immunization with Heat- 
Killed Pneumococcus, Type I 
Immunity  to  Type  I 
Num-  Total  (homologous) 
Number  berof  amount 
of  injec-  in- 
rabbits  tions  jected  Sur- 
co.  vived  Die 
Immunity to Type III  Protective 
(heterologous)  capadty  for 
inlce 
27  0.1  3  --  -- 
16  0.2  3 
0.1  3 
0.01  3 
14  --  -- 
29  --  -- 
20  ~ 
10  ~ 
20  --  m 
-  1.0 
-  0.8 
--  0.5 
--  1.0 
0.5 
--  1.0 
0.8 
0.5 
-  1.0 
0.5 
-  1.0 
0.5 
-  0.5 
0.3 
0.1 
0.01 
0.001 
Sur-  Num-  Degree 
cc.  rived  Died  berseraOf tection°f  pro- 
2  --  -- 
m 
:  1  i 
I  2 
! 
!  3 
2 
2 
1 
I 
11 
1 
1 
i  - 
i 
2 
2 
Anfi-S fitre 
2  none  negative 
1  10-6  1-1 :  1 
1  10 -2  1:20 
1  1  10 -~  1:1 
2  10 -4  1:5 
1  2  10 -5  negative 
1  10  -6  negative 
--  2  none  negative 
--  5  none  negative 
--  4  none  negative 
2 
2  5  none  negative 
B 
--  2  none  negative 
--  1  10-6  negative 
--  1  none  negative 
1 
2  9  none  negative 
2 
M. L. D. of Type I  culture for normal rabbits, 10 -7 cc.; for mice 10 -~ cc. 
M. L. D. of Type III culture for normal rabbits, 10 -4 cc.; for mice 10 -7 cc. 
* In  this instance,  all  nine rabbits were tested first for resistance to Type  I 
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but this question has not been studied.  He observed that, following 
intravenous  {mmunization  with  R  pneumococci,  rabbits  not  only 
acquired an active resistance but that  the sera of these animals, pas- 
sively transferred to other rabbits, protected them  against  infection 
with pneumococci of every type.  These sera, however, afforded no 
protection to mice against pneumococcal infection. 
II.  Immunization with Type Ill (S) Pneumococcus 
Thirty-eight  rabbits were immunized by intracutaneous  injections 
of heat-killed Type III pneumococci (Table II).  These animals were 
subsequently tested for active immunity to virulent cultures of Type 
• I or Type III Pneumococcus. 
(a) Active Immunity to Infection by Type III  (Homologous) Pneu- 
mococcus.  Resistance to infection by pneumococci of the homologous 
type was tested in 9 rabbits. 
They were immunized by 8 injections into the skin of heat-killed  pneumococci 
Type III, the total number of bacteria corresponding to those contained in 16 cc. 
of broth culture.  All the animals were subsequently infected by intravenous in- 
jections of varying amounts of culture in quantities as large as 1.0 cc.  The cul- 
ture employed killed normal rabbits in doses of 0.0001 cc.  One of the animals died 
and 2 survived after receiving 0.5 cc. of culture, 2 died and 1 survived after 0.8 
cc., and 1 died and 2 survived after 1.0 cc. of culture.  In the 4 animals which 
succumbed, death was delayed from the seventh to the tenth day after the infec- 
tion, and in each instance, the post-mortem examination revealed a massive peri- 
carditis and pleurisy.  The delayed death and localization of the infection may be 
considered to be an expression of active immunity. 
It is obvious that  these animals  showed a  considerable  degree of 
active immunity to infection with homologous organisms. 
(b) Active Immunity to fnfection by Type f  Pneumococcus  (Heterol- 
ogous).  Twenty-eight  rabbits  which  had  been  immunized  by  the 
intracutaneous injection of heat-killed pneumococci (Type iii)  were 
later  tested for their  immunity  against  infection  with  heterologous 
(Type I) pneumococci (Table II).  The culture employed in the tests 
was of such a  virulence  that  0.0,000,001  cc.  injected intravenously 
regularly  killed  normal  rabbits.  The  immunized  animals  received 
doses of from 0.001 to 0.2 ce.  Of the 28 immunized animals  receiving 
these large doses, 22 recovered and only6 died.  It is evident~ there- 
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acquired a  marked  resistance  against  pneumoccci of  a  heterologous 
type. 
(c)  Passive Immunity.  It is well known that only in rare instances 
is the serum of a  rabbit immunized intravenously to Type  III  Pneu- 
Resistance of 
TABLE  II 
Rabbits to  Infection Following Intracutaneous Immunization  with 
Heat-Killed Pneumococcus, Type III 
Num-  Total 
Number  ber of  amount 
of  injec-  in- 
rabbits  tions  jected 
9  8  16 
3  12  27 
5  7  14 
4  14  29 
5  10  20 
6  7  14 
5  7  14 
Immunity to  Type III 
(homologous) 
Immunity to  Type I 
(hetcrologous) 
Protective 
caI~tY for 
IDACe 
Num-  Degree 
Sur-  Died  cc.  Sur-  Died i ber of  of pro-  cc.  rived  rived  ~ra  tectlon 
Anfi-S fit~e 
1.0  2  1 
0.8  1  2 
0.5  2  1 
9  none  negative 
--  --  --  0.01  3  --  3  none  negative 
......  S  none  negative 
--  0.1  1  1 
0.01  2  --  4  none  negative 
--  0.2  --  1 
0.1  1  -- 
0.01  1  1 
5  none  negative 
--  0.1  1  1 
0.01  2  -- 
0.001  2  -- 
--  0.1  2  -- 
0.01  1  1 
0.001  1  -- 
5  none  negative 
mococcus protective for white mice against infection with homologous 
organisms.  In the experiments here  recorded  (Table II)  the  sera of 
37  rabbits which were immunized intracutaneously  with  suspensions 
o~ heat-killed pneumococci Type III  were tested  for  their protective 
power in  white  mice,  and  in  no  instance  did  these  sera  confer  any LOUIS  A.  JULIANELLE  455 
measurable protection.  Moreover, in none of the sera were any type- 
specific antibodies demonstrable. 
According to the recent work of Sia (4) normal pig serum, though 
lacking type-specific agglufinins, protects mice against infection by 
Pneumococcus  of any type.  The special technique which he employed 
was used in retesting six of the sera mentioned above.  Three of these 
sera were from the animals immunized by the injection of Type III 
pneumococci and  three  from  the  rabbits  immunized with  Type  I 
pneumococci.  The  serum  was  injected intraperitoneally  into  the 
mice 4 hours preceding_the inoculation of the live culture.  No protec- 
tive power could be demonstrated in any of these sera by this method. 
The Rate of Development and Duration of Active Immunity Following 
Intracutaneous Injections 
Having determined that rabbits, following repeated intracutaneous 
immunization, acquire a marked resistance to infection by Pneumo- 
coccus of any type, observations were next made to determine how 
rapidly this form of active immunity develops and how long it per- 
sists. 
Fourteen  rabbits  were  immunized,  employing  a  varying  number of  intracutan- 
eous injections  and different  amounts of heat-killed  bacteria  (Table  III (a)). 
Each of  two animals  received  from I  to  7  injections  of  the  bacteria,  corresponding 
to 2 cc. to 14 cc. of Type I pncumococcal culture. Three weeks after  the last 
iDjection,  the  immunity to  infection  was  measured  against  Type III  pneumococci. 
Thc results  show that cvcn after one intracutaneous  injection of 
pneumococci, in an amount corresponding to  2.0 cc.  of  culture,  rabbits 
may show a distinct  rcsistance to infection  with hcterologous  pneu- 
mococci.  Of  the  14  rabbits,  thc scra  of  only  2  showed any anti-S  agglu- 
tinating power.  In one rabbit,  which had received 4 injections,  the 
agglutination titrc  of the serum was 1:3,  and in the other,  which had 
received 7 injections,  the titrc  was only i:5.  The protective action 
of these sera  for  mice was very low and irregular,  only 3 sera affording 
minor protection against homologous  infection.  Curiously enough, 
the 2 sera  possessing specific  agglutinins afforded no protection to 
white mice. 
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TABLE  III 
Rate of Devdopment and Duration of Immunity in Rabbits Immunized  with Heat- 
Killed Pneumococcus Type I  by the Intracutaneous Route 
(a) Rate of Development 
Number  Total 
Number  of  amount 
of rabbits , injections  injected 
2  '  1 
2  2 
2  3 
2  4 
2  5 
2  6 
2  7 
Immunity to Type HI  Protective capacity 
(heterologous)  for mice 
Anti-S 
cc.  Survived  Died  Number  Degree of 
of tera  protection 
C¢. 
2  0.01  1  -- 
O. 01  1  --  2  none  negative 
4  0.1  1  -- 
O. 3  1  --  2  none  negative 
6  0.3  1  -- 
0.5  1  --  2  none  negative 
8  O. 5  1  --  1  none  negative 
0.5  1  --  1  none  1 : 3 
10  0.5  1  --  1  none  negative 
0.8  1  --  1  10  -s  negative 
12  0.8  1  --  1  10  -s  negative 
1.0  1  --  1  none  negative 
14  O. 5  --  1  1  none  negative 
1.0  1  --  1  none  1 : 5 
(b) Duration of Immunity 
Animals Immunized  with Pneumococcus, Type III 
Immunity to Type I 
(heterologous)  after 6 months  Number 
of rabbits 
Numb~ 
of 
injections 
Total 
~nount 
injected 
$$. 
16 
16 
16 
16 
16 
16 
cc.  Survived  Died 
10-x  --  1 
10  ~  --  1 
lO-t  --  1 
10  -~  1  -- 
10  -6  1  -- 
10-*  1  -- 
Protective capacity  Anti-S 
for mice 
All  sera  negative  both  10 
days  and  6  months  after 
final injection LOUIS  A.  JULIANELLE  457 
by intracutaneous injections of a  suspension of Type III organisms 
corresponding to a  total amount of 16 c c. of culture.  Six months 
after the final injection the animals were infected with Type I Pneu- 
mococcus culture in amounts varying from one-tenth to one-millionth 
cc.  As shown in the table the animals were resistant to infection with 
one-ten-thousandth  cc.  It  appears,  therefore,  that  resistance to 
heterologous infection still persists after six months although at this 
time it is considerably diminished. 
Resistance  to  Infection  Following  Intracuaneous  Immunization  with 
Suspensions of Heat-Killed R  Cells of Pneumococcus 
The R  strain used for immunization was originally derived from a 
Type II Pneumococcus.  Rabbits were immunized by intracutaneous 
injections of suspensions  of heat-killed pneumococci  in a manner similar 
to  immunization with  S  cells.  The  animals  received  amounts of 
suspension equivalent to those usually employed in intravenous im- 
munization.  Resistance to infection was measured by injecting intra- 
venously different quantities of a virulent culture of Type I pneumo- 
cocci.  The results given in Table IV show that 4 rabbits immunized 
to R  pneumococci survived following the injection of 0.01  cc. or 0.1 
cc. of a Type I  Pneumococcus culture which killed normal rabbits in 
a dilution of 0.0,000,001  cc.  The sera of the rabbits immunized with 
R organisms derived from Type II pneumococci afforded white mice 
no protection against infection by Type II pneumococci.  The sera 
also did not agglutinate Type II pneumococci. 
Resistance  to  Infection Following  [ntracutaneous  Immunization with 
Soluble Derivatives of Pneumococcus 
It has previously been shown that following intracutaneous immun- 
ization with S or R pneumococci,  rabbits acquire an active immunity 
to infection by homologous and heterologous types of pneumocoeci. 
It was also shown in a previous paper (1) that the antibody response 
in the majority of rabbits is the same (species-specific) whether intra- 
cutaneous immunization is brought about by the injection of formed 
cells or by the injection of soluble derivatives of Pneumococcus.  The 
present observations were made to determine whether, following in- 
traeutaneous injections of solutions containing soluble derivatives of 458  INTRACUTANEOUS  INJECTIONS  OF  PNEU~[OCOCCI.  II 
Pneumococcus, rabbits  become actively immune to  infection with 
living cultures. 
The animals received (a) a solution of "nudeoprotein," and (b) the supernatant 
fluid after acid precipitation of the "nucleoprotein" from a solution of pneumococci 
resulting from repeated freezing and thawing.  These solutions were prepared from 
a culture of Type II Pneumococcus in the same manner as described in the previous 
paper (1). 
The rabbits receiving "nucleoprotein" were given repeated injections, the total 
amount of protein administered to each animal, as estimated by nitrogen deter- 
TABLE  IV 
Resistanc~ of Rabbits  to Infection Following Intracutaneous  Immunization with R 
Forms and with Soluble Protein Deri'vatives of the Cell 
Antigen administered 
R Pneumococcus 
Derived from Type 
II "S" 
Nudeoprotein 
Derived  from  Type 
II "S" 
Supematant  after 
removal of nucleo- 
protein 
Num- 
ber of 
rabbits 
Quantity 
of antigen 
20 CE. 
70 mgm. 
30 mgm. 
Immunity to  Type I  Protection  conferred  by  sera 
(heterologous)  on  mice (homologous infection) 
CC. 
10-1 
10-s 
10-3  I 
10-4 
10-6 
10-B 
10-~ 
10-4 
10-6 
10-6 
Sur- 
'  rived 
2 
i  2 
1 
1 
Died 
1 
1 
1 
1 
1 
Num-  Degree ] 
berof  of pro-] 
sera  tection 
n¢ ae 
nc De 
1( -6 
nc  ne 
I( -6 
Anti-S titre 
negative 
negative 
negative 
negative 
negative 
mination, being 70 mg.  Three weeks following the last immunizing injectior~, 
they were given intravenously varying quantities of a virulent Type I  Pneumo- 
coccus culture.  The results, as shown in Table IV, indicate that the immunity 
induced in these animals was extremely slight; indeed it may be doubted whether 
any increased resistance was demonstrated.  In the sera of none of these animals 
were type-specific antibodies demonstrable and only one of the sera possessed any 
protective power for mice, in this case of minimal degree. 
The rabbits receiving the second material were given repeated injections, the 
total amount of solution containing 30 mgm. of protein as estimated on the basis 
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results of the subsequent  injection of different  amounts of Type I  Pneumococcus 
culture.  The data are given in Table IV and it is seen that little immunity follows 
the intracutaneous  injection of this material.  The  sera of none of the rabbits 
possessed type-specific antibodies and the serum of only one of them protected mice 
against a minimal infective dose.  The sera of  these  rabbits,  however, did  con- 
tain species-specific antibodies,  as was shown by their power to precipitate the 
"nucleo-protein" and to agglutinate R  cells. 
The results show, then, that repeated injections of soluble deriva- 
tives of Pneumococcus into the skin do not render rabbits resistant to 
infection.  Tillett  (S)  has already  pointed  out  that  rabbits  do not 
acquire an active immunity following intravenous immunization with 
solutions of Pneumococcus. 
TABLE V 
Protective Property of  Sera of  Rabbits Immunized Intravenously after Previous 
Intracutaneous Immunization 
Number of rabbits  Previous 
immunization 
Intracutaneous 
Type I 
Intracutaneous 
Type III 
Later 
immunization 
Intravenous 
Type I 
Intravenous 
Type I 
Protection fitre for mice 
Number of sera  Degree of protection 
CC° 
0.2 
0.1 
0.2 
0.1 
0.01 
Protective  Properties  of  Sera  of  Rabbits  Immunized  Intravenously 
Following a Previous Intracutaneous Immunization 
It was shown in the preceding  communication  (1)  that  previous 
intracutaneous  immunization does  not  render  rabbits  incapable  of 
forming type-specific  antibodies when they  are  subsequently  given 
intravenous injections.  It was interesting to determine the protection 
titre of the sera of rabbits immunized first by intracutaneous inocula- 
tions  and  later  by  intravenous  injections.  The  data  presented  in 
Table V show that 12 rabbits were originally immunized by intracu- 
taneous  injections  of suspensions of  heat-killed  pneumococci.  Six 
were immunized to Type I and six to Type III pneumococci.  At the 
end of  the immunization, none of the sera conferred protection upon 460  INTRACUTANEOUS  INJECTIONS  Ol  ~ PNEU]~OCOCCI.  II 
white mice to infection by pneumococci of the respective types, and 
none contained type-specific antibodies.  After a subsequent immun- 
ization by intravenous injections of Type I  pneumococci the sera of 
all 12 rabbits not only showed a high agglutination titre (about 1 : 160) 
but all conferred a high grade of passive protection upon mice  against 
infection by Pneumococcus Type I. 
DISCUSSION 
The results of the preceding communication (1)  disclose the fact 
that  immunization by  the intracutaneous injection of  suspensions 
of heat-killed pneumococci, whether S or R, incites the formation of 
species-specific antibodies in all rabbits.  In the animals immunized 
with Type IIl pneumococci no type-specific antibodies were found, 
and in the rabbits immunized with Type I  pneumococci antibodies 
appeared in only  12  per cent of the rabbits studied.  The present 
study  reveals  that  following intracutaneous immunization rabbits 
acquire a marked degree of resistance to intravenous infection by pneu- 
mococci, and that this is true whether the pneumococci injected be of 
the same type as those employed in  immunization or of a  different 
type.  This active immunity is effective even in the absence of type- 
specific agglutinins. 
In general, the sera of rabbits immunized by intracutaneous injec- 
tions fail to protect white mice against infection by Pneumococcus. 
However, when pneumococci  of Type I are employed in the immuniza- 
tion, about 20 per cent of the sera studied conferred on white mice some 
degree of protection against infection. 
Tillett was the first to point out (5) that the intravenous immuniza- 
tion with R  or S cells of any type of Pneumococcus renders  rabbits 
actively immune to  infection with  Type III Pneumococcus.  In a 
subsequent communication Tillett showed (3) that although the sera 
of rabbits intravenously immunized to R or S pneumococci failed to 
protect white mice against infection by Pneumococcus, nevertheless, 
these sera did confer protection upon normal rabbits.  Later Goodner 
(6) reported that rabbits recovering from an intracutaneous infection 
with live virulent cultures of Type I Pneumococcus  were subsequently 
immune to infection with pneumococci of the same type.  1VIore  re- 
cently Bull  and  McKee  (7)  found that  following immunization of LOUIS  A.  JULIANELLE  461 
rabbits by subcutaneous and intravenous injections of pneumococci 
of Type II or Type III and by similar injections of a  strain of pneu- 
mococci of Group IV the animals were actively immune, and that this 
immunity was effective against intransal or intravenous injections of 
pneumococci  of Type I.  Species-specific antibodies were present in the 
sera of all the animals.  Type-specific agglutinins were present in the 
sera of the rabbits immunized against Pneumococcus of Type II and 
in the serum of the animals immunized against a Pneumococcus be- 
longing in Group IV.  In previous papers (8, 9) Bull and McKee had 
demonstrated that rabbits in which cultures of Type I pneumococci 
had been instilled into the nose were subsequently actively immune  to 
infection with the homologous organism, and this in the absence of 
demonstrable type-specific antibodies. 
On the other hand~ the intracutaneous injections of soluble deriva- 
tives of pneumococci  in rabbits is not followed by an active resistance 
to infection with these organisms and the sera of these animals fail 
to protect white mice against infection. 
The observations made in this study indicate, then, that an active 
and broad resistance to infection by Pneumococcus may be present 
in the absence of circulating type-specific antibodies.  Active immu- 
nity to pneumococcal infection is usually considered to be associated 
with the development of demonstrable antibodies which in one way 
or another react specifically with the bacteria themselves.  The sera 
of animals immunized in the usual manner by repeated intravenous 
injections usually afford passive protection against infection by corre- 
sponding types of Pneumococcus  to animals of various species and the 
passive protection is considered to depend Upon the transfer of type- 
specific antibodies.  In rabbits immunized by intracutaneous injec- 
tions, however, the active resistance to infection which develops Ires 
been found to be unrelated to type-specificity as is evidenced both by 
the absence of type-specific antibodies in the serum and by the fact 
that the resistance to infection which these animals exhibit is effective, 
not only against pneumococci  of the homologous type, but also against 
infection with  pneumococci of  heterologous type.  Moreover,  the 
sera of these animals do not, as a rule, confer passive protection upon 
white mice against infection even by homologous  types of pneumococci. 
It is possible that in the one case the resistance is dependent upon the 
development  of a new property, an acquired active immunity, and that 462  INTRACUTANEOUS  INJECTIONS OF  PNEUMOCOCCI.  II 
in the other case the resistance depends upon an exaltation of a  natu- 
rally occurring property, an increase in natural resistance to infection, 
but this cannot be determined from the data at hand. 
SUMMARY AND  CONCLUSIONS 
1.  Injection of suspensions of heat-killed pneumococci into the skin 
of rabbits is followed by an active immunity which is effective against 
intravenous infection by homologous and heterologous types of Pneu- 
mococcus. 
2. This form of  active  immunity may be induced by the  injection  of 
S or I~ strains  of Pneumococcus. 
3. Intracutaneous immunization with soluble  derivatives of Pneu- 
mococcus does not induce active  immunity to infection. 
4. The sera of seventy-nine  per cent of the rabbits  immunized to 
Type I Pneumococeus  by intracutaneous  injections  afforded no pro- 
tection  to mice against infection  with pneurnococci. 
5. None of the sera  of rabbits intracutaneously  immunized to the 
type-specific  Type III (S)  pneumococci, to  R cells,  or  to  soluble  deriva- 
tives  of Pneumococcus protected white mice against infection. 
6. The sera  of rabbits immunized first  intracutaneously and subse- 
quently intravenously  possess a high titre  of protective antibodies. 
7. It may be concluded that when type-specific  pnettmococci are 
injected into the skin they lose  the property of stimulating an active 
immunity of  a specific  type and of  stimulating the  production of type- 
specifi  c antibodies,  but they act just  as do the degraded or R forms, 
causing the  animals to become resistant  to  infection  with pneumococci 
of a11 types without the development of any type-specific  antibodies 
in  the serum. 
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